Pfizer SG&A Expenses 2010-2024 | PFE

Pfizer sg&a expenses for the twelve months ending September 30, 2024 were $15.031B, a 1.28% increase year-over-year.

  • Pfizer annual sg&a expenses for 2023 were $14.771B, a 8% increase from 2022.
  • Pfizer annual sg&a expenses for 2022 were $13.677B, a 7.67% increase from 2021.
  • Pfizer annual sg&a expenses for 2021 were $12.703B, a 9.54% increase from 2020.

Pfizer SG&A Expenses 2010-2024 | PFE

  • Pfizer annual sg&a expenses for 2023 were $14.771B, a 8% increase from 2022.
  • Pfizer annual sg&a expenses for 2022 were $13.677B, a 7.67% increase from 2021.
  • Pfizer annual sg&a expenses for 2021 were $12.703B, a 9.54% increase from 2020.